1. Home
  2. EVO vs BASE Comparison

EVO vs BASE Comparison

Compare EVO & BASE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • BASE
  • Stock Information
  • Founded
  • EVO 1993
  • BASE 2011
  • Country
  • EVO Germany
  • BASE United States
  • Employees
  • EVO N/A
  • BASE N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • BASE EDP Services
  • Sector
  • EVO Health Care
  • BASE Technology
  • Exchange
  • EVO Nasdaq
  • BASE Nasdaq
  • Market Cap
  • EVO 1.5B
  • BASE 1.3B
  • IPO Year
  • EVO 2021
  • BASE 2021
  • Fundamental
  • Price
  • EVO $4.26
  • BASE $24.27
  • Analyst Decision
  • EVO Buy
  • BASE Hold
  • Analyst Count
  • EVO 2
  • BASE 16
  • Target Price
  • EVO $5.90
  • BASE $22.97
  • AVG Volume (30 Days)
  • EVO 95.8K
  • BASE 812.8K
  • Earning Date
  • EVO 08-13-2025
  • BASE 09-03-2025
  • Dividend Yield
  • EVO N/A
  • BASE N/A
  • EPS Growth
  • EVO N/A
  • BASE N/A
  • EPS
  • EVO N/A
  • BASE N/A
  • Revenue
  • EVO $851,944,444.00
  • BASE $214,662,000.00
  • Revenue This Year
  • EVO $10.08
  • BASE $12.41
  • Revenue Next Year
  • EVO $10.99
  • BASE $13.95
  • P/E Ratio
  • EVO N/A
  • BASE N/A
  • Revenue Growth
  • EVO 1.50
  • BASE 12.76
  • 52 Week Low
  • EVO $2.84
  • BASE $12.78
  • 52 Week High
  • EVO $5.64
  • BASE $25.16
  • Technical
  • Relative Strength Index (RSI)
  • EVO 55.61
  • BASE 71.37
  • Support Level
  • EVO $3.64
  • BASE $24.20
  • Resistance Level
  • EVO $4.36
  • BASE $24.32
  • Average True Range (ATR)
  • EVO 0.09
  • BASE 0.12
  • MACD
  • EVO -0.01
  • BASE -0.23
  • Stochastic Oscillator
  • EVO 86.11
  • BASE 40.00

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About BASE Couchbase Inc.

Couchbase Inc provides a modern cloud database that offers the robust capabilities required for business-critical applications on a scalable and available platform. It empower developers and architects to build, deploy and run mission-critical applications. Couchbase delivers a high-performance, flexible and scalable modern database that runs across the data center and any cloud. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: